A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation NCT05512767 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Head and Neck C...
Stage II Hypoph...
Stage II Laryng...
Stage II Lip an...
Stage II Oropha...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Best Practice
Consensus Audit...
Diagnostic Imag...
Lymphedema Mana...
Modified Barium...
Nasopharyngeal ...
Pneumatic Compr...
Quality-of-Life...
Questionnaire A...
Voice Handicap ...
18 Years - Mayo Clinic View Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer NCT06084845 Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Oral Cavity Squ...
Oropharyngeal S...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Cutane...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Biospecimen Col...
Carboplatin
Chest Radiograp...
Cisplatin
Computed Tomogr...
Image Guided Ra...
Intensity-Modul...
Magnetic Resona...
Positron Emissi...
Xevinapant
18 Years - Eastern Cooperative Oncology Group View Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer NCT05172245 Clinical Stage ...
Head and Neck C...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Maxillary Sinus...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage III Sinon...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Stage IVB Sinon...
Biopsy
Biospecimen Col...
Cisplatin
Computed Tomogr...
Ipatasertib
Magnetic Resona...
Positron Emissi...
Radiation Thera...
18 Years - National Cancer Institute (NCI) View Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin NCT04533750 Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI) View Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin NCT04533750 Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI) View Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin NCT03258554 Clinical Stage ...
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Oral Cavity Squ...
Oropharyngeal S...
Pathologic Stag...
Squamous Cell C...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Cetuximab
Durvalumab
Intensity-Modul...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - National Cancer Institute (NCI) View A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation NCT05512767 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Head and Neck C...
Stage II Hypoph...
Stage II Laryng...
Stage II Lip an...
Stage II Oropha...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Best Practice
Consensus Audit...
Diagnostic Imag...
Lymphedema Mana...
Modified Barium...
Nasopharyngeal ...
Pneumatic Compr...
Quality-of-Life...
Questionnaire A...
Voice Handicap ...
18 Years - Mayo Clinic View Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer NCT04870840 Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Poste...
Stage II Cutane...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Unresectable He...
Unresectable Or...
Proton Beam Rad...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study NCT05136196 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Lip and Oral Ca...
Melanoma
Oropharyngeal S...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI) View Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer NCT04870840 Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Poste...
Stage II Cutane...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Unresectable He...
Unresectable Or...
Proton Beam Rad...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery NCT02734537 Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Laryngeal Squam...
Lip and Oral Ca...
p16INK4a Negati...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oral ...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oral ...
Stage IVA Oroph...
Cisplatin
Intensity-Modul...
Laboratory Biom...
18 Years - Eastern Cooperative Oncology Group View Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer NCT04870840 Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Poste...
Stage II Cutane...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Unresectable He...
Unresectable Or...
Proton Beam Rad...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study NCT05136196 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Lip and Oral Ca...
Melanoma
Oropharyngeal S...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI) View Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer NCT03010150 Carcinoma of Un...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Head...
Metastatic Mali...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage I Hypopha...
Stage I Nasopha...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Nasoph...
Stage IV Oropha...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Nasop...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Nasop...
Stage IVB Oroph...
Biospecimen Col...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer NCT04162873 Clinical Stage ...
Clinical Stage ...
Nasal Cavity an...
Oral Cavity Car...
Pathologic Stag...
Pathologic Stag...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Nasal...
Recurrent Oral ...
Recurrent Oroph...
Stage III Hypop...
Stage III Laryn...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Oropha...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Oroph...
Stage IVC Hypop...
Stage IVC Laryn...
Stage IVC Oroph...
Celecoxib
Placebo
Quality-of-Life...
Questionnaire A...
18 Years - University of Utah View Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer NCT04576091 Clinical Stage ...
Clinical Stage ...
Recurrent Cutan...
Recurrent Head ...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Paran...
Recurrent Saliv...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Major...
Stage III Oroph...
Stage III Sinon...
Stage IV Cutane...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Major ...
Stage IV Oropha...
Stage IV Sinona...
Unresectable Cu...
Unresectable He...
Unresectable Hy...
Unresectable La...
Unresectable Or...
Unresectable Or...
Unresectable Pa...
Unresectable Sa...
Biospecimen Col...
Computed Tomogr...
Elimusertib
Pembrolizumab
Positron Emissi...
Quality-of-Life...
Stereotactic Bo...
18 Years - National Cancer Institute (NCI) View Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery NCT02734537 Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Laryngeal Squam...
Lip and Oral Ca...
p16INK4a Negati...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oral ...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oral ...
Stage IVA Oroph...
Cisplatin
Intensity-Modul...
Laboratory Biom...
18 Years - Eastern Cooperative Oncology Group View A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation NCT05512767 Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Head and Neck C...
Stage II Hypoph...
Stage II Laryng...
Stage II Lip an...
Stage II Oropha...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Best Practice
Consensus Audit...
Diagnostic Imag...
Lymphedema Mana...
Modified Barium...
Nasopharyngeal ...
Pneumatic Compr...
Quality-of-Life...
Questionnaire A...
Voice Handicap ...
18 Years - Mayo Clinic View